Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-myeloablative Conditioning”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006350
What this trial is testing

Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Not applicableStudy completedNCT01687231
What this trial is testing

Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets

Who this might be right for
Hematologic Malignancies
Duke University 47
Testing effectiveness (Phase 2)Study completedNCT01969435
What this trial is testing

Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma

Who this might be right for
Hodgkin DiseaseLymphoma, Non-Hodgkin
Washington University School of Medicine 50
Testing effectiveness (Phase 2)Looking for participantsNCT07225985
What this trial is testing

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent T-Cell Non-Hodgkin LymphomaRefractory T-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02144025
What this trial is testing

Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT

Who this might be right for
Graft-Versus-Host Disease
Hospital Universitario Dr. Jose E. Gonzalez 21
Early research (Phase 1)Looking for participantsNCT07015684
What this trial is testing

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

Who this might be right for
Sickling Disorder Due to Hemoglobin S
Columbia University 24
Testing effectiveness (Phase 2)UnknownNCT00093522
What this trial is testing

Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
St. Luke's Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT00003572
What this trial is testing

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Study completedNCT00006417
What this trial is testing

Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00896493
What this trial is testing

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Who this might be right for
MycosesSezary SyndromeLymphoma, T-Cell, Cutaneous+3 more
Stanford University 38
Not applicableStudy completedNCT00342316
What this trial is testing

Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Vastra Gotaland Region 340
Not applicableStudy completedNCT00682799
What this trial is testing

Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)

Who this might be right for
Refractory Cytopenia of ChildhoodReduced Intensity Conditioning (RIC)Myelodysplastic Syndrome (MDS)+1 more
Charlotte Niemeyer, MD 112
Large-scale testing (Phase 3)Study completedNCT00354120
What this trial is testing

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

Who this might be right for
Acute Myeloblastic LeukemiaLymphoblastic LeukemiaMyelodysplasia+3 more
Gruppo Italiano Trapianto di Midollo Osseo 121
Not applicableUnknownNCT01850108
What this trial is testing

Non-Myeloablative Conditioning and Bone Marrow Transplantation

Who this might be right for
Sickle Cell DiseaseHemoglobinopathies
Vanderbilt-Ingram Cancer Center 26
Testing effectiveness (Phase 2)UnknownNCT01156350
What this trial is testing

Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma

Who this might be right for
Neuroblastoma
University Hospital, Clermont-Ferrand 10
Testing effectiveness (Phase 2)Study completedNCT01203020
What this trial is testing

Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation

Who this might be right for
Hodgkin's LymphomaNon-Hodgkin's Lymphoma
West Virginia University 22
Testing effectiveness (Phase 2)Study completedNCT02989844
What this trial is testing

Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT

Who this might be right for
Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)
Masonic Cancer Center, University of Minnesota 20
Testing effectiveness (Phase 2)Study completedNCT04716075
What this trial is testing

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

Who this might be right for
Chronic Lymphocytic LeukemiaChronic Graft-versus-host-diseaseMantle Cell Lymphoma+2 more
Polish Lymphoma Research Group 29
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00028600
What this trial is testing

Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
Alliance for Clinical Trials in Oncology 60
Next Page